| |
OR (95% CI)* |
P* |
OR (95%CI)** |
P** |
| Age |
|
0.1 |
|
0.70 |
| Male gender |
|
0.2 |
|
0.1 |
| IDU |
2.5 (1.6-3.9) |
<0.001 |
2.0 (0.9-4.1) |
0.08 |
| <100% Adherence |
-- |
-- |
11.1 (3.8-33) |
<0.001 |
| HAART change |
1.8 (1.0-3.2) |
0.03 |
|
0.4 |
| Any toxicity |
|
0.2 |
2.0 (0.9-4.5) |
0.08 |
| Treated in 1998 |
3.6 (2.2-5.7) |
<0.001 |
3.1(1.5-6.3) |
0.003 |
* Logistic regression model including 514 observations, with an area under the
ROC curve = 0.74 and a Hosmer-Lemeshow goodness of fit test p-value= 0.3. **
Logistic regression model including only those patients for whom adherence data
were available (n=255), with an area under the ROC curve = 0.80 and a Hosmer-
Lemeshow goodness of fit test p-value= 0.5. |
